These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 26182979)

  • 1. Apparent diffusion coefficient maps integrated in whole-body MRI examination for the evaluation of tumor response to chemotherapy in patients with multiple myeloma.
    Bonaffini PA; Ippolito D; Casiraghi A; Besostri V; Franzesi CT; Sironi S
    Acad Radiol; 2015 Sep; 22(9):1163-71. PubMed ID: 26182979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminating Depth of Response to Therapy in Multiple Myeloma Using Whole-body Diffusion-weighted MRI with Apparent Diffusion Coefficient: Preliminary Results From a Single-center Study.
    Wu C; Huang J; Xu WB; Guan YJ; Ling HW; Mi JQ; Yan H
    Acad Radiol; 2018 Jul; 25(7):904-914. PubMed ID: 29373210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application value of diffusion weighted whole body imaging with background body signal suppression in monitoring the response to treatment of bone marrow involvement in lymphoma.
    Sun M; Cheng J; Zhang Y; Wang F; Meng Y; Fu X
    J Magn Reson Imaging; 2016 Dec; 44(6):1522-1529. PubMed ID: 27160047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: preliminary results.
    Horger M; Weisel K; Horger W; Mroue A; Fenchel M; Lichy M
    AJR Am J Roentgenol; 2011 Jun; 196(6):W790-5. PubMed ID: 21606271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-weighted whole-body MRI for evaluation of early response in multiple myeloma.
    Lacognata C; Crimì F; Guolo A; Varin C; De March E; Vio S; Ponzoni A; Barilà G; Lico A; Branca A; De Biasi E; Gherlinzoni F; Scapin V; Bissoli E; Berno T; Zambello R
    Clin Radiol; 2017 Oct; 72(10):850-857. PubMed ID: 28587715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Squamous Cell Carcinoma of the Head and Neck: Comparison of Diffusion-weighted MRI at b-values of 1,000 and 2,000 s/mm(2) to Predict Response to Induction Chemotherapy.
    Ryoo I; Kim JH; Choi SH; Sohn CH; Kim SC
    Magn Reson Med Sci; 2015; 14(4):337-45. PubMed ID: 26104081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade.
    Giganti F; De Cobelli F; Canevari C; Orsenigo E; Gallivanone F; Esposito A; Castiglioni I; Ambrosi A; Albarello L; Mazza E; Gianolli L; Staudacher C; Del Maschio A
    J Magn Reson Imaging; 2014 Nov; 40(5):1147-57. PubMed ID: 24214734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma.
    Narquin S; Ingrand P; Azais I; Delwail V; Vialle R; Boucebci S; Tasu JP
    Diagn Interv Imaging; 2013 Jun; 94(6):629-36. PubMed ID: 23683788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very early indicators of response to systemic therapy in lymphoma patients based on alterations in water diffusivity--a preliminary experience in 20 patients undergoing whole-body diffusion-weighted imaging.
    Horger M; Claussen C; Kramer U; Fenchel M; Lichy M; Kaufmann S
    Eur J Radiol; 2014 Sep; 83(9):1655-64. PubMed ID: 24972451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Diffuse Bone Marrow Infiltration Pattern in Monoclonal Plasma Cell Diseases by Quantitative Whole-body Magnetic Resonance Imaging.
    Sun M; Cheng J; Ren C; Zhang Y; Li Y; Wang L; Zhang S; Lin L
    Acad Radiol; 2022 Apr; 29(4):490-500. PubMed ID: 34362664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body diffusion-weighted MRI for evaluation of response in multiple myeloma patients following bortezomib-based therapy: A large single-center cohort study.
    Zhang Y; Xiong X; Fu Z; Dai H; Yao F; Liu D; Deng S; Hu C
    Eur J Radiol; 2019 Nov; 120():108695. PubMed ID: 31589995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of different MRI sequences in lesion detection and early response evaluation of diffuse large B-cell lymphoma--a whole-body MRI and diffusion-weighted imaging study.
    Wu X; Nerisho S; Dastidar P; Ryymin P; Järvenpää R; Pertovaara H; Eskola H; Kellokumpu-Lehtinen PL
    NMR Biomed; 2013 Sep; 26(9):1186-94. PubMed ID: 23483722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravoxel Incoherent Motion Diffusion-weighted Imaging of Multiple Myeloma Lesions: Correlation with Whole-Body Dynamic Contrast Agent-enhanced MR Imaging.
    Bourillon C; Rahmouni A; Lin C; Belhadj K; Beaussart P; Vignaud A; Zerbib P; Pigneur F; Cuenod CA; Bessalem H; Cavet M; Boutekadjirt A; Haioun C; Luciani A
    Radiology; 2015 Dec; 277(3):773-83. PubMed ID: 26131910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of diffusion-weighted imaging with background body signal suppression for staging, prognosis, morphology, treatment response, and apparent diffusion coefficient in plasma-cell neoplasms: A single-center, retrospective study.
    Yamada A; Araki Y; Tanaka Y; Otsuki S; Yamada A; Moriyama M; Katagiri S; Suguro T; Asano M; Yoshizawa S; Akahane D; Furuya N; Fujimoto H; Okabe S; Gotoh M; Suzuki K; Saito K; Gotoh A
    PLoS One; 2021; 16(7):e0253025. PubMed ID: 34242226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-treatment staging of multiple myeloma patients: comparison of whole-body diffusion weighted imaging with whole-body T1-weighted contrast-enhanced imaging.
    Squillaci E; Bolacchi F; Altobelli S; Franceschini L; Bergamini A; Cantonetti M; Simonetti G
    Acta Radiol; 2015 Jun; 56(6):733-8. PubMed ID: 24973257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep Learning for Automatic Bone Marrow Apparent Diffusion Coefficient Measurements From Whole-Body Magnetic Resonance Imaging in Patients With Multiple Myeloma: A Retrospective Multicenter Study.
    Wennmann M; Neher P; Stanczyk N; Kahl KC; Kächele J; Weru V; Hielscher T; Grözinger M; Chmelik J; Zhang KS; Bauer F; Nonnenmacher T; Debic M; Sauer S; Rotkopf LT; Jauch A; Schlamp K; Mai EK; Weinhold N; Afat S; Horger M; Goldschmidt H; Schlemmer HP; Weber TF; Delorme S; Kurz FT; Maier-Hein K
    Invest Radiol; 2023 Apr; 58(4):273-282. PubMed ID: 36256790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of malignant and benign renal lesions using diffusion-weighted MRI with multiple b values.
    Erbay G; Koc Z; Karadeli E; Kuzgunbay B; Goren MR; Bal N
    Acta Radiol; 2012 Apr; 53(3):359-65. PubMed ID: 22334870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated Shimming Improves Lesion Detection in Whole-Body Diffusion-Weighted Examinations of Patients With Plasma Disorder at 3 T.
    Zhang H; Xue H; Alto S; Hui L; Kannengiesser S; Berthold K; Jin Z
    Invest Radiol; 2016 May; 51(5):297-305. PubMed ID: 26704452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-body diffusion-weighted MR imaging for assessment of treatment response in myeloma.
    Giles SL; Messiou C; Collins DJ; Morgan VA; Simpkin CJ; West S; Davies FE; Morgan GJ; deSouza NM
    Radiology; 2014 Jun; 271(3):785-94. PubMed ID: 24475858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal characteristics of focal bone marrow lesions in patients with multiple myeloma using whole body T1w-TSE, T2w-STIR and diffusion-weighted imaging with background suppression.
    Sommer G; Klarhöfer M; Lenz C; Scheffler K; Bongartz G; Winter L
    Eur Radiol; 2011 Apr; 21(4):857-62. PubMed ID: 20853109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.